Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2011 Jun 29.
Published in final edited form as: Circulation. 2010 Jun 29;121(25):2755–2765. doi: 10.1161/CIRCULATIONAHA.109.893461

Cardiovascular effects of ambient particulate air pollution exposure

Qinghua Sun 1,2,3, Xinru Hong 4, Loren E Wold 3,5,6,7
PMCID: PMC2924678  NIHMSID: NIHMS213443  PMID: 20585020

Introduction

An association between high levels of air pollutants and human disease has been known for more than half a century. Air pollution is composed of a heterogeneous mixture of compounds including ozone (O3), carbon monoxide (CO), sulfur dioxide (SO2), nitrogen oxides (NOx), liquids and particulate matter (PM). Substantial epidemiological evidence implicates air pollution, in particular PM, as a major risk factor with serious consequences on human health.1-3 Of particular interest in PM are the particles that are ≤ 10 μm in diameter (PM10), since these are the PM that ultimately enter the lungs.4 PM is further divided into coarse (10 to 2.5 μm, PM10-2.5), fine (<2.5 μm, PM2.5) and ultrafine particles (<0.1 μm, PM0.1).1 These particles are composed of solid and liquid components that originate from vehicle exhaust, road dust, smokestacks, forest fires, windblown soil, volcanic emissions, and sea spray. Particle size, surface area, and chemical composition determine the health risk posed by PM. Particulate and gaseous pollutants co-exist in the air and may both induce adverse health effects, whereas compelling data implicate PM as a major perpetrator of various types of human disease. PM rarely exists by itself within the ambient environment since gaseous and semi-volatile/volatile compounds (i.e. aldehydes and polycyclic aromatic hydrocarbons) are constantly changing and interacting. Many of these vapor-phase compounds attach to the surface of PM and/or themselves form secondary aerosol particles.

Due to their small size, PM2.5 and PM0.1 are inhaled deeply into the lungs, with a portion depositing in the alveoli and entering the pulmonary circulation, and presumably the systemic circulation. The adverse effects of PM on the cardiovascular system have been established in a series of major epidemiologic and observational studies.5-9 Although life expectancy has been improved significantly since air pollution levels have been reduced,10-13 the mechanisms of the effects of air pollution on cardiovascular disease remain unclear. In this review, primary effects of PM on the cardiovascular system will be summarized, along with potential mechanisms involved in disease progression. In addition, PM-exaggerated cardiovascular-associated disorders, such as obesity and metabolic syndrome, are also described in relation to progression following PM exposure.

Cardiac Events and Hospital Admission

Cardiac function requires an appropriate interplay among three key components: balanced tone of the autonomic nervous system, adequate myocardial function as the motor unit, and rhythmic initiation and conduction of electrical impulses to maintain the sequence and latency of atrial and ventricular activation and repolarization.14 PM exposure can result in significant changes in many cardiovascular indices, such as heart rate, heart rate variability, blood pressure, and blood coagulability.

Epidemiological studies have shown an association between air pollution and adverse health effects since the 1930s.15 In the 1970s, broad investigations were conducted on human health, in particular pulmonary and cardiovascular diseases.16-18 Since the 1990s, studies concerning air pollution and cardiovascular diseases have intensified, especially regarding cardiovascular mortality and hospital admission for sudden cardiac events.19-23 Specifically, Burnett et al. examined the effect of ambient air pollution on cardiac disease exaggeration by relating daily fluctuations in admissions to 134 hospitals for congestive heart failure in the elderly to daily variations in ambient concentrations of CO, NO2, SO2, O3, and the coefficient of haze in Canada’s 10 largest cities for the 11-year period 1981-1991. They found that the daily high-hour ambient CO concentration recorded on the day of admission displayed the strongest and most consistent association with hospitalization rates among the pollutants.19 The same group studied the ambient air pollution mix on cardiorespiratory disease exacerbation in the summers of 1992, 1993, and 1994, and found that the increase in O3, NO2, and SO2 corresponded to an 11% and 13% increase in daily hospitalizations for respiratory and cardiac diseases, respectively. The inclusion of any one of the particulate air pollutants in multiple regression models did not increase these percentages.20

To examine effect size estimates across large differences in both the levels of potential confounding factors and in their correlation with airborne particle concentration, particle concentration was found to be a significant risk factor for elevated mortality, and the relative risk was for a 100 mg/m3 increase in TSP concentration.21 To separate the effects of different air pollutants, daily counts of admissions to all hospitals in Tucson, AZ for cardiovascular disease in persons age ≥ 65 years were analyzed, and indicated that both PM10 and CO were associated with increased risk of cardiovascular hospital admissions with admissions increased by 2.75% for an interquartile range increase (23 mg/m3) in PM10 and by 2.79% for an interquartile range increase (1.66 parts per million) in CO.23 It is increasingly recognized that exposure to ambient PM contributes to significant adverse health effects and is a risk factor for the development of ischemic cardiovascular events via exacerbation of atherosclerosis, coronary artery disease, and the triggering of myocardial infarction, even within hours following exposure.24 Studies have demonstrated a significant elevation in the incidence of life-threatening myocardial infarctions25 and cardiac arrhythmias26 in the immediate periods (hours to days) following exposure to high levels of atmospheric PM2.5.

PM pollution is also linked to an increased risk for hospital admission for cardiovascular and respiratory diseases,27 increased risk of myocardial infarction among the elderly,28 triggering of acute cardiac decompensation in heart failure patients,29 and an increase in the rate of hospital admissions for exacerbation of congestive heart failure.30 Recently, variations in the relative risk of hospitalization associated with ambient exposure to PM2.5 total mass and chemical composition was investigated in the U.S. from 1999 through 2005. This study found a positive statistically significant association between county-specific estimates of the short-term effects of PM2.5 on cardiovascular and respiratory hospitalizations and county-specific levels of vanadium, elemental carbon, or nickel PM2.5 content, especially in the Northeast region.31, 32 There is a body of literature, as early as the 1970s,33 indicating a correlation between air pollution and hospital admission for an acute event. Table 1 depicts selected investigations regarding air pollution and hospital admissions, particularly due to sudden cardiac events.

Table 1.

The Effect of Air Pollution on Acute Hospital Admission

Author
s
Key Findings Diseases Poll
utan
ts
Subj
ect
Yea
r
Locati
on
Ref
eren
ce
Burnett
, et al
Exposure associated with 11% and
13% increased daily hospitalizations
for respiratory and cardiac diseases,
respectively
Respirato
ry and
cardiac
diseases
PM1
0,
O3,
NO2
,
SO2,
CO
Not
spe
cific
199
2-
199
4
Ontari
o,
Cana
da
20
Domini
ci, et al
Short-term exposure to PM2.5
associated with increased hospital
admission for cardiovascular and
respiratory diseases
Cardiova
scular
and
respirator
y disease
PM2.
5
>65
year
s
199
9-
200
2
204
US
counti
es
27
Welleni
us, et
al
Exposure associated with increased
hospital admission for CHF, with
CHF PM1
0
≥65
year
s
198
6-
199
9
7 US
cities
30
Bell, et
al
Strong relationship between PM2.5
and hospitalization due to respiratory
and cardiovascular diseases,
especially in the Northeast region,
with a 1.49% increase in
hospitalizations of cardiovascular
diseases per 10-μg/m3 increase in
same-day PM2.5,
Respirato
ry and
cardiovas
cular
diseases
PM2.
5
≥65
year
s
199
9-
200
5
202
US
counti
es
31
Bell, et
al
Higher PM2.5 content of nickel,
vanadium, and elemental carbon
associated with higher risk of
cardiovascular and respiratory
hospitalizations
Cardiova
scular
and
respirator
y
diseases
PM2.
5 &
che
mic
al
com
posi
tion
≥65
year
s
199
9-
200
5
106
US
counti
es
32
Morga
n, et al
Exposure associated with increased
hospitalization for respiratory and
heart disease, with increase in daily
maximum 1-hour particulate
concentration associated with an
increase of 3.01% in COPD and
2.82% in heart disease admissions
Respirato
ry and
heart
disease
PM2.
5,
O3,
NO2
,
PM1
0
All
age
s
199
0-
199
4
Sydne
y,
Austr
alia
34
Schwa
rtz, et
al
Exposure associated with hospital
admissions for heart disease, with
daily variation in PM10 associated
with 2.48% increase and daily
variation in CO associated with
2.79% increase
Heart
disease
PM1
0,
CO
≥65
year
s
198
8-
199
0
8 US
counti
es
35
Presco
tt, et al
Exposure associated with
emergency hospital admission from
cardiac and respiratory disease,
positive
association with PM10 and negative
association
with O3
Cardiac
and
respirator
y disease
PM1
0,
CO,
NO2
, O3
All
age
s
198
1-
199
5
UK 36
Linn, et
al
Exposure associated with increased
hospitalization for cardiopulmonary
illness, with a 25th-75th percentile
increase in CO predicted an
increase of 4% in cardiovascular
admission, and NO2 and PM10 but
not O3 showed similar increases in
cardiovascular disease
Cardiopul
monary
disease
PM1
0,
CO,
NO2
, O3
Adul
ts
199
2-
199
5
Los
Angel
es,
US
37
Jansse
n, et al
PM10 associated with hospital
admissions, especially for
cardiovascular disease in 14 cities in
summer and winter
Cardiova
scular
disease
PM1
0
Not
spe
cific
199
3
14 US
cities
38
Wong,
et al
Air pollution has similar associations
with daily cardiorespiratory
admissions in both cities with
significant positive association
observed with PM10, NO2, SO2, and
O3 in both cities
Cardiores
piratory
disease
PM1
0,
O3,
SO2,
NO2
All
age
s
199
2-
199
7
Hong
Kong,
Londo
n
39
McGo
wan, et
al
PM10 exposure associated with
cardio-respiratory admission, with
3.37% increase in respiratory
admissions and 1.26% rise in
cardiac admissions for each
interquartile rise in PM10
Cardio-
respirator
y disease
PM1
0,
CO,
SO2,
NOx
All
age
s
198
8-
199
8
New
Zeala
nd
40
Mann,
et al
Exposure associated with hospital
admission for myocardial infarction,
with a 1-ppm increase in CO
associated with a 3.60% increase in
same-day IHD admissions with a
secondary diagnosis of CHF, a
2.99% increase in persons with a
secondary diagnosis of ARR, and a
1.62% increase in IHD admissions in
persons without either secondary
diagnosis
Myocardi
al
infarction
PM1
0,
NO2
, CO
≥40
year
s
198
8-
199
5
Califo
rnia,
US
41
Koken,
et al
Exposure associated with increased
hospitalization for cardiovascular
disease, with O3 associated with an
increase in the risk of hospitalization
for acute myocardial infarction,
coronary atherosclerosis, and
pulmonary heart disease, SO2 for
cardiac dysrhythmias, and CO for
congestive heart failure
Cardiova
scular
disease
PM1
0,
CO,
SO2,
O3,
NO2
>65
year
s
199
3-
199
7
Color
ado,
US
42
Fung,
et al
Exposure to SO2 associated with
daily cardiac hospital admission,
with the percentage increase in daily
admission 2.6% for current day SO2,
4.0% for 2-day mean level, and
5.6% for 3-day mean level for an
increase in interquartile range of
19.3 ppb, and the contributing effect
of SO2 remained significant for all
three levels when PM10 included
Cardiac
disease
SO2,
PM1
0
≥65
year
s
199
5-
200
0
Ontari
o,
Cana
da
43
Chang,
et al
Exposure, especially to PM10,
associated with increased hospital
admissions for cardiovascular
disease
Cardiova
scular
disease
PM1
0,
O3,
NO2
, CO
Not
spe
cific
199
7-
200
1
Taiwa
n
44
Hossei
npoor,
et al
CO exposure associated with
increased hospitalization due to
angina pectoris, with each unit
increase in CO caused a 1.00
increase in the number of
admissions
Angina
pectoris
NO2
,
CO,
O3,
SO2,
PM1
0
Not
spe
cific
199
6-
200
1
Iran 45
Mahes
waran,
et al
Exposure associated with coronary
heart disease mortality and hospital
admission, with admission rate ratios
1.00, 1.01, and 0.88 to the lowest
NOx, PM10, and CO quintile
categories, respectively
Coronary
heart
disease
NOx
,
PM1
0,
CO
≥45
year
s
199
4-
199
8
UK 46
Welleni
us, et
al
Exposure associated with transiently
increased ischemia, but not
hemorrhagic, stroke, with an
interquartile range increase in PM10
associated with a 1.03% increase in
admissions for ischemic stroke on
the same day
Cardiac
ischemia
PM1
0
≥65
year
s
199
0
9 US
cities
47
Low, et
al
Exposure associated with stroke
hospital admission, with statistically
significant, independent
exacerbating effects of SO2 and
PM10
Stroke O3,
NO2
,
SO2,
CO,
PM1
Adul
ts
199
5-
200
5
New
York
City,
NY
48
Barnett
, et al
Exposure associated with adult
cardiovascular hospital admissions,
with all pollutants except O3
significantly associated with five
categories of cardiovascular disease
admissions in the elderly
Cardiova
scular
disease
NO2
,
CO,
PM2.
5,
PM1
0, O3
All
age
s
199
8-
200
1
Austr
alia,
New
Zeala
nd
49
Johnst
on, et
al
PM10 exposure positively associated
with respiratory disease and
ischaemic heart disease admissions,
especially in indigenous people
Respirato
ry
disease
PM1
0
All
age
s
200
0-
200
5
Austr
alia
50
Migliar
etti, et
al
Significant association between the
increase in emergency hospital
admission for respiratory causes and
exposure, with a mean increase in
emergency hospital attendance of
2.20% and 2.55% per 10 μg/m3
increase in exposure to SO2 and
TSP, respectively, and a mean
increase of 5.30% per 1 mg/m3
increase in exposure to CO.
Respirato
ry
disease
SO2,
CO,
TSP
Adul
ts
199
7-
199
9
Italy 51
Peng,
et al
Significant associations between
PM10-2.5 and hospital admissions for
cardiovascular and respiratory
diseases, with a 10-μg/m3 increase
in PM10-2.5 associated with a 0.36%
increase in cardiovascular disease
admissions on the same day
Cardiova
scular
and
respirator
y
diseases
PM2.
5,
PM1
0,
PM1
0-2.5
>65
year
s
199
9-
200
5
US 52
Yang,
et al
CHF admission associated with air
pollutants on warm days in the
single-pollutant model of PM10, NO2,
CO, or O3
CHF PM1
0,
NO2
,
CO,
O3
Adul
ts
199
6-
200
4
Taiwa
n
53
Middlet
on, et
al
Increased risk of hospitalization with
PM10 and O3, with every 10 μg/m3
increase in daily average PM10
associated with a 0.9% increase in
all-cause and 1.2% increase in
cardiovascular admissions
All-
cause,
especiall
y
cardiovas
cular
disease
PM1
0, O3
All
age
s
199
9-
200
4
Cypru
s
54
Lin, et
al
Positive association between
respiratory hospital admissions and
ambient O3 level 2 days prior to
admission in 5 of the 11 regions
Respirato
ry
disease
O3 0-17
year
s
199
9-
200
1
New
York
State
55

Note: CHF, chronic heart failure; O3, ozone; CO, carbon monoxide; NO2, nitrogen dioxide; BC, black carbon; OC, organic carbon; SO2, Sulfur dioxide; TSP, total suspended particulate; NOx, nitrogen oxides. IHD, ischemic heart disease; ARR, arrhythmia

Changes in Heart Rate and Cardiac Function

In an attempt to investigate associations between ambient PM and cardiovascular function in a repeated measures study in Boston residents, exposure to PM2.5 with an average concentration of 15.5 μg/m3 was associated with decreased vagal tone, resulting in reduced heart rate variability.56 In another study that evaluated changes in mean heart rate and heart rate variability in humans, there was an association between exposure to PM10 on a previous day by 100 μg/m3 with significantly increased heart rate by 5-10 beats/min, suggesting that changes in cardiac autonomic function, reflected by changes in mean heart rate and heart rate variability, may be part of the pathophysiological mechanism linking cardiovascular mortality and PM.57 In the ULTRA (Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air) study 58, elevations in PM predicted risk for exercise-induced ST-segment depression in subjects with coronary artery disease. Another study in 3,827 participants who underwent cardiac magnetic resonance imaging between 2000 and 2002 found that participants living within 50 miles of a major roadway had a higher cardiac function-left ventricular mass index (LVMI) associated with PM2.5 elevation, indicating chronic vascular end-organ damage from traffic-related environmental exposure.59 Several other studies have demonstrated a link between changes in heart rate and PM levels in mice60 and elderly humans.61 The possible mechanisms involved in these events include disturbances in cardiac autonomic control,62 reduction in cardiac vagal control,63 decreases in parasympathetic tone,64 and an imbalance in cardiac autonomic control.65

Thrombosis and Other Changes in Hemostasis

PM has been associated with transient increases in plasma viscosity, acute-phase reactants, and endothelial dysfunction, as well as altered autonomic control of the heart. The effect of intravenous or intratracheal administration of ultrafine polystyrene particles, diesel exhaust particles, or PM2.5 on thrombus formation was investigated, indicating the effects of circulating particles on changes in hemostasis.66-71 In 3256 randomly selected men and women aged 25-64 years, high concentrations of SO2, CO, and TSP were associated with increased plasma viscosity.72 The Holland group studied approximately 330 deaths during 1986 to 1994 and found that embolisms and thrombotic changes were increased following exposure to CO, O3, and SO2.73 In a double-blind randomized crossover study, 20 healthy volunteers were exposed to dilute diesel exhaust and filtered air in UK and Sweden; thrombus formation, coagulation, platelet activation and inflammatory markers were measured post-exposure. These investigators found that diesel exhaust inhalation increased thrombus formation, platelet-neutrophil and platelet-monocyte aggregates.74

Other epidemiological data link PM exposure to an augmentation of systemic inflammation, as measured by C-reactive protein (CRP),26 an acute phase protein associated with adverse outcomes in patients with unstable ischemic syndromes. In this prospective cohort survey in 1984/85 with a 3-year follow-up of 631 randomly selected men aged 45 to 64 years free of cardiovascular disease at entry, the odds of observing CRP concentrations above 5.7 mg/L (>90th percentile) tripled at normal ambient PM concentrations, and increases of 26 μg/m3 total suspended particles (mean of 5 days) raised the odds of having a CRP level 50% greater than the 90th percentile.26 Increased levels of fibrinogen, platelets and white blood cell counts were also associated with exposure to TSP.75, 76

The regulation of fibrinolysis is another important aspect of endothelial function. Small areas of endothelial denudation and thrombus deposition are a common finding on the surface of atheromas and are usually subclinical. Therefore, endogenous fibrinolysis of the lesion might prevent thrombus propagation and vessel occlusion.77 Nevertheless, under adverse proinflammatory states or imbalances in the fibrinolytic system, microthrombi may progagate and ultimately lead to arterial occlusion and tissue infarction.78 In a series of double-blind, randomized crossover studies, both healthy men and patients with stable coronary artery disease were exposed to dilute diesel exhaust (PM 300 μg/m3) for one hour while performing intermittent exercise.79-81, and were then challenged by intrabrachial bradykinin, acetylcholine, sodium nitroprusside, and verapamil. Although there was a dose-dependent increase in blood flow with each vasodilator, this response was attenuated with bradykinin, acetylcholine, and sodium nitroprusside infusions two hours after exposure to diesel exhaust, which persisted at six hours. Bradykinin caused a dose-dependent increase in plasma tissue plasminogen activator that was suppressed six hours after exposure to diesel.79 In a double-blind, randomized, crossover study, 20 men with a prior myocardial infarction were exposed, in two separate sessions, to dilute diesel exhaust (300 μg/m3) or filtered air for one hour during periods of rest and moderate exercise in a controlled-exposure facility. Exercise-induced ST-segment depression was found in all patients, but there was a greater increase in the ischemic burden during exposure to diesel exhaust. Exposure to diesel exhaust reduced the acute release of endothelial tissue plasminogen activator other than aggravating preexisting vasomotor dysfunction.81 In these studies, the acute release of tissue plasminogen activator (t-PA), which is a key regulator of endogenous fibrinolytic capacity, was reduced after diesel exhaust inhalation. This effect persisted for six hours following initial exposure,79 with the magnitude of this reduction comparable to that seen in cigarette smokers.82 This antifibrinolytic effect further underscores the prothrombotic potential of air pollution, especially under circumstances of vascular injury.

Baccarelli et al have performed several studies regarding air pollution exposure and changes in blood homeostasis. To investigate the association between pollution levels (PM10, CO, NO2, SO2, and O3) and changes in global coagulation tests, such as prothrombin time (PT) and activated partial thromboplastin time (APTT), 1218 normal subjects from the Lombardia Region, Italy were tested and it was shown that air pollution is associated with changes in global coagulation function, suggesting a tendency towards hypercoagulability after short-term exposure to air pollution.83 The effects of exposure to PM10 on risk of developing deep vein thrombosis (DVT) in 870 patients and 1210 controls from the Lombardy region in Italy between 1995 and 2005 was then tested, with findings suggesting that long-term exposure to PM10 is associated with altered coagulation function and DVT risk.84 Using distance from roads as a proxy for traffic exposure to further investigate whether living near major traffic roads increased the risk of deep vein thrombosis, 663 patients with DVT of the lower limbs and 859 age-matched controls from cities with populations >15, 000 inhabitants in the Lombardia Region of Italy from 1995 through 2005 were examined. It was found that the risk of developing DVT was increased for subjects living near a major traffic road compared with those living further away, which was approximately linear over the observed distance range and was not modified after adjusting for background levels of PM, indicating that living near major traffic roads is associated with an increased risk of developing DVT.85 A summary of these effects is presented in Table 2.

Table 2.

The Effect of Air Pollution on Changes in Blood Homeostasis

Author
s
Key Findings Pollut
ants
Subj
ect
Yea
r
Locatio
n
Ref
eren
ce
Peters,
et al
Exposure associated with
increased plasma viscosity, with
the odds ratio 3.6 for plasma
viscosity above the 95th percentile
of the distribution comparing
measurements during the air
pollution episode with non-episode
measurements in men and the
odds ratio 2.3 for women
TSP,
SO2,
CO
25-
64
year
s
198
4-
198
5
Augsbu
rg,
Germa
ny
72
Hoek,
et al
Exposure associated with
increased embolism, thrombosis,
and mortality, with heart failure
deaths responsible for about 30%
of the cardiovascular deaths
related to PM10, SO2, CO, and NO2
PM10,
CO,
SO2,
NO2
All
age
s
198
6-
199
4
The
Netherl
ands
73
Luckin
g, et al
Exposure associated with
increased ex vivo thrombus
formation and in vivo platelet
activation, with increased
thrombus formation under low- and
high-shear conditions by 24% and
19%, respectively
Diesel
exhau
st
21-
44
year
s
200
8
UK,
Swede
n
74
Mills,
et al
Exposure associated with inhibition
of endogenous fibrinolytic capacity,
with a greater increase in the
ischemic burden during exposure
to diesel exhaust
Diesel
exhau
st
59-
61
year
s
200
7
UK 81
Baccar
elli, et
al
Exposure associated with changes
in global coagulation function, with
PT shorter with higher PM10 and
NO2
PM10,
NO2,
SO2,
CO,
O3
11-
84
year
s
199
5-
200
5
Italy 83
Baccar
elli, et
al
Exposure associated with altered
coagulation function and DVT risk,
with each increase of 10 μg/m3 in
PM10 associated with a 70%
increase in DVT risk
PM10 18-
84
year
s
199
5-
200
5
Italy 84
Baccar
elli, et
al
Living near major traffic roads is
associated with increased risk of
DVT, with the increase in DVT risk
approximately linear over the
observed distance range from 718
to 0 meters
Not
specifi
c
(dista
nce
from
major
roads)
18-
84
199
5-
200
5
Italy 85
Ray, et
al
Exposure associated with
activated circulating platelets and
increased leukocyte-platelet
aggregates, with the MFI of CD11b
on the surface of circulating
monocytes and PMN of biomass
users increased by 50 and 68%,
respectively, and a 62 and 48%
increase in MFI observed in CD18
expression on the surface of these
cells in biomass users
PM2.
5,
PM10
21-
60
year
s
200
3-
200
4
India 86

Note: DVT, deep venous thrombosis; O3, ozone; CO, carbon monoxide; NO2, nitrogen dioxide; SO2, Sulfur dioxide; TSP, total suspended particulate; MFI, mean fluorescence intensity; PMN, polymorphonuclear leukocytes; PT, prothrombin time

Atherosclerosis

The main pathway by which PM contributes to increased cardiac risk is by initiating and promoting atherosclerotic progression, the underlying cause of most cardiovascular diseases.87-89 Atherosclerotic lesions can lead to ischemia of the heart, brain, or extremities. The disruption of a vulnerable but not necessarily stenotic atherosclerotic plaque in response to hemodynamic stress has been suggested as a mechanism that can trigger a myocardial infarction. Air pollution may induce atherosclerosis in the peripheral arteries, coronary arteries and aorta. Acute exposure to elevated PM has been associated with increased acute cardiovascular mortality, especially with an at risk subset of the population, whereas prolonged exposure has been considered as a causative factor for atherosclerosis.1 In an epidemiological study, Pope et al reported that PM2.5 exposure is a risk factor for cause-specific cardiovascular disease mortality via mechanisms that likely include pulmonary and systemic inflammation, accelerated atherosclerosis, and altered cardiac autonomic function.7 The precise pathway through which PM induces initiation and progression of atherosclerosis has not been determined, but two hypotheses have been proposed and assessed experimentally. The original hypothesis proposed that inhaled particles provoke an inflammatory response in the lungs, with consequent release of prothrombotic and inflammatory cytokines into the circulation.90 The alternative pathway proposed that inhaled, insoluble PM2.5 or PM0.1 could rapidly translocate into the circulation, with the potential for direct effects on homeostasis and cardiovascular integrity.91 The ability of PM0.1 to cross the lung-blood barrier is likely to be influenced by a number of factors including particle size and charge, chemical composition, and propensity to form aggregates.3 Once in the circulation, PM0.1 can interact with the vascular endothelium or have direct effects on atherosclerotic plaques, causing local oxidative stress and pro-inflammatory effects similar to those seen in the lungs. Either through direct translocation into the circulation or via secondary pulmonary-derived mediators, PM augments atherogenesis and causes acute adverse thrombotic and vascular effects.

In a series of animal models, mice fed high fat chow and exposed to ambient PM2.5 demonstrated marked increases in plaque area, macrophage infiltration, expression of the inducible isoform of nitric oxide synthase, increased generation of reactive oxygen species, and greater immunostaining for the protein nitration product 3-nitrotyrosine, indicating that exposure to low concentrations of PM2.5 altered vasomotor tone, induced vascular inflammation, and potentiated atherosclerosis.92, 93 Consistently, Chen and Nadziejko exposed the ApoE knockout mice and ApoE, LDLr-deficient mice to ambient PM2.5 94 and demonstrated that subchronic exposure to ambient PM in these mice had a significant impact on the size, severity, and composition of aortic plaque. The PM0.1 component could have a greater atherogenic effect than the PM2.5 fraction. Araujo et al compared the proatherogenic effects of ambient particles of <0.18 μm (ultrafine particles) with particles of <2.5 μm in apoE knockout mice.95 Ultrafine PM-exposed mice exhibited significantly larger early atherosclerotic lesions than mice exposed to PM2.5 or filtered air. Also, exposure to ultrafine particles resulted in an inhibition of the anti-inflammatory capacity of plasma high-density lipoprotein and greater systemic oxidative stress. Their data showed that exposure to concentrated ultrafine PM rich in polycyclic aromatic hydrocarbons produced more inflammation, systemic oxidative stress, and atheroma formation than the fine fraction in apoE-knockout mice. In the Watanabe heritable hyperlipidemic rabbit model, four-week exposure to ambient PM10 resulted in dose-dependent alveolar and systemic inflammatory responses and progression of atherosclerosis in the coronary arteries and the aorta.89 The volume fraction of coronary atherosclerotic lesions was increased in response to PM10 exposure. The atherogenic effects correlated with the extent of PM phagocytosed by alveolar macrophages in the lung and coupled with an enhanced release of bone marrow monocytes. These precursors of macrophages play a key role in atherogenic inflammatory responses. In addition, exposure to PM10 also caused an increase in plaque cell turnover and extracellular lipid pools in coronary and aortic lesions, as well as in the total amount of lipids in aortic lesions. Therefore, progression of atherosclerosis and increased vulnerability to plaque rupture may underlie the relationship between PM and increased cardiovascular death.

A panel study in Los Angeles provided the first evidence of a link between chronic PM exposure and atherosclerosis in humans.96 This study using data from 798 participants of two clinical trials found that a 10-μg/m3 increase in PM2.5 was associated with an increase in carotid intima-media thickness (CIMT), an ultrasonic measure of atheroma. For a cross-sectional exposure contrast of 10 μg/m3 PM2.5, CIMT increased by 5.9% (95% confidence interval, 1-11%). Adjustment for age reduced the coefficients, but further adjustment for covariates indicated robust estimates in the range of 3.9-4.3%. Among older subjects (≥60 years of age), women, never smokers, and those reporting lipid-lowering treatment at baseline, the associations of PM2.5 and CIMT were larger with the strongest associations in women 60 years of age (15.7%, 5.7-26.6%), suggesting that chronic ambient PM exposure may affect the development of atherosclerosis in humans. In a study examining the role of traffic-related, long-term exposure to PM2.5 (mean concentration 22.8 μg/m3) in 4494 adult participants from the Heinz Nixdorf Recall Study, , a 50% reduction in the distance between the residence and a main road resulted in a 10.2% increase in coronary artery calcification.97 These studies support the concept that air pollution causes a progression of atherosclerosis. In a cross-sectional analysis, Allen et al investigated exposure to PM2.5 and residential proximity to major roads in relation to abdominal aortic calcification, a sensitive indicator of systemic atherosclerosis.98 Aortic calcification was measured by computed tomography among 1147 persons, in five US metropolitan areas, enrolled in the Multi-Ethnic Study of Atherosclerosis. They found a slightly elevated risk of aortic calcification with a 10 μg/m contrast in PM2.5, and the PM2.5-associated risk of aortic calcification was stronger among participants with long-term residence near a PM2.5 monitor and among participants not recently employed outside the home. Their findings revealed a strong relationship between ambient PM and systemic atherosclerosis. A summary of these effects on the development of atherosclerosis is presented in Table 3.

Table 3.

The Effect of Air Pollution on the Development of Atherosclerosis

Author
s
Key Findings Polluta
nts
Subje
ct
Year Location Refer
ence
Pope,
et al
Exposure associated with
acute ischemic coronary
events (unstable angina
and myocardial infarction),
with PM2.5 elevated by 10
μg/m3 associated with
increased risk of acute
ischemic coronary events
equal to 4.5%
PM2.5 Adults 1994-
2004
US 8
Kunzli,
et al
Exposure associated with
an increase in carotid
intima-media thickness,
with a cross-sectional
exposure contrast of 10
μg/m3 PM2.5, CIMT
increased by 5.9%
PM2.5 ≥40
years
1998-
2003
California
, US
96
Hoffma
nn, et
al
Long-term residential
exposure associated with
coronary atherosclerosis,
with a reduction in the
distance between the
residence and a major
road by half associated
with a 7.0% higher CAC
PM2.5 45-74
years
2000-
2003
Germany 97
Allen,
et al
Associations with systemic
atherosclerosis stronger
among participants with
less exposure, with
elevated risk of aortic
calcification with a 10
μg/m contrast in PM2.5
PM2.5 45-84
years
2000-
2002
US 98

Note: CIMT, carotid intima-media thickness; CAC, coronary artery calcification

Vasomotor Tone Alterations and Hypertension

The effect of air pollution on vascular dysfunction and blood pressure change has been investigated in both humans and animals for years. In 2607 men and women aged 25 to 64 years who participated in the Augsburg Monitoring of Trends and Determinants in Cardiovascular Disease survey in association with air pollution episodes in Europe in January 1985, continuous concentrations of TSP and SO2 were associated with an increase in systolic blood pressure.99 To investigate the associations between PM2.5 and blood pressure during 631 repeated visits for cardiac rehabilitation in 62 Boston residents with cardiovascular disease, data analyses indicated that for an increase from the 10th to the 90th percentile in mean PM2.5 levels during the 5 days prior to the visit (10.5 μg/m3), there was a 2.8-mm Hg increase in resting systolic, a 2.7-mm Hg increase in resting diastolic, and a 2.7-mm Hg increase in resting mean arterial blood pressure. The mean PM2.5 level during the two preceding days (13.9 μg/m3) was associated with a 7.0-mm Hg increase in diastolic and a 4.7-mm Hg increase in mean arterial blood pressure during exercise in persons with resting heart rate ≥70 bpm, but not associated with an increase in blood pressure during exercise in persons with heart rate <70 bpm.100 In a study conducted in Italy comparing 68 traffic policemen and 62 controls (all male) at rest and during a symptom-limited incremental exercise test, 26 traffic policemen and none of the controls experienced exercise-induced ECG abnormalities or hypertension, along with the traffic exposed group demonstrated a number of significant changes in cardiorespiratory measures on exercise testing, suggesting that chronic occupational exposure to urban pollutants reduces resistance to physical effort and increases the risk of cardiovascular and respiratory effects.101

In an investigation of 40 healthy white male nonsmokers spontaneously breathing ambient air in Paris, France, gaseous pollutants were found to affect large artery endothelial function, whereas PM exaggerated the dilatory response of small arteries to ischemia.102 In detail, reactive hyperemia was significantly and positively correlated with PM10-2.5. An increase in PM, 2 weeks apart, was significantly correlated with an increase in reactive hyperemia. Endothelial function was impaired by ordinary levels of pollution in healthy young males, in an urban area, and may be reduced by 50% between the least and the most polluted day.102 Potential mechanisms for PM-associated changes in blood pressure have been suggested to include an increase in sympathetic tone and/or the modulation of basal systemic vascular tone.103 Two studies showing associations between air pollution and blood pressure followed subjects with chronic obstructive pulmonary disease (COPD). Linn et al found that an increase of 33 μg/m3 ambient PM10 was associated with a 5.7 mmHg increase in systolic blood pressure.104 In contrast, Brauer et al studied 16 non-smoking COPD patients residing in Vancouver equipped with a PM2.5 monitor for seven 24-h periods, and found that although no associations between air pollution and lung function were statistically significant, weak associations were observed between particle concentrations and increased supraventricular ectopic heartbeats and with decreased systolic blood pressure. No consistent associations were observed between any particle metric and diastolic blood prressure, heart rate, heart rate variability (r-MSSD or SDNN), symptom severity, or bronchodilator use. Of the pollutants measured, ambient PM10 was most consistently associated with health parameters.105 In nonsmoking healthy and asthmatic volunteers exposed to concentrated fine ambient particulates (CAP) compared to filtered air (FA), systolic blood pressure was decreased in asthmatics and increased in healthy subjects during CAP exposure relative to FA. Cardiovascular (but not respiratory) symptoms increased slightly with CAP in both groups.106 However, in 25 healthy adults exposed to two-hour inhalation of approximately 150 μg/m3 of CAP plus O3, exposure to CAP plus O3 caused a significant brachial artery vasoconstriction compared with FA inhalation,107 suggesting that PM2.5 CAP exposure (with/without O3) were found to be inversely associated with systolic blood pressure in asthmatics, but positively associated in healthy subjects.106, 107

In addition to the epidemiological and clinical studies, animal studies have provided evidence regarding the mechanism of action of air pollution exposure-induced changes in blood pressure. In an angiotensin II-induced hypertensive Sprague-Dawley rat model, exposure to concentrated ambient PM2.5 for 10 weeks induced prolonged blood pressure recovery compared to the filtered air (FA)-exposed group.108 In this study, aortic vasoconstriction to phenylephrine was potentiated with exaggerated relaxation to the Rho-kinase (ROCK) inhibitor Y-27632 and an increase in ROCK-1 mRNA levels and superoxide production in the PM2.5-exposed group, suggesting that short-term PM2.5 exposure exaggerates hypertension through superoxide-mediated upregulation of the Rho/ROCK pathway.108 Subsequently, in a murine model exposed to concentrated ambient PM2.5 for 12 weeks followed by a 14-day angiotensin II infusion in conjunction with fasudil, a Rho kinase antagonist, PM2.5 exposure was found to potentiate angiotensin II-induced hypertension, which was abolished with fasudil treatment.109 In addition, PM2.5 exposure increased angiotensin II-induced cardiac hypertrophy, collagen deposition, and cardiac and vascular RhoA activation, suggesting that cardiovascular health effects are indeed the results of air pollution exposure.109

Other Cardiovascular-Associated Events

Air pollution exposure has been shown to be linked to cerebrovascular diseases, such as stroke. In a study conducted in England and Wales in the early 1980s, stroke mortality showed strong correlations with atmospheric pollution levels, both in the winter and summer. These correlations were strengthened by standardization for season and for temperature.110 By examining death certificates in Philadelphia on 5% of the days with the highest particulate air pollution and 5% of the days with the lowest particulate air pollution during the years 1973-1980, the relative risk of dying from a stroke was elevated on days of high pollution.22 The effect of air pollution exposure on stroke has also been confirmed in Japan in 1980-1995 during the summer season.111 In a recent investigation examining the association of long-term exposure to PM2.5 with cardiovascular events, 65,893 postmenopausal women without previous cardiovascular disease in 36 U.S. metropolitan areas from 1994 to 1998 were studied. The results showed that each increase of 10 μg/m3 was associated with a 24% increase in the risk of a cardiovascular event and a 76% increase in the risk of death from cardiovascular disease. The risk of cerebrovascular events was also associated with increased levels of PM2.5.9

Air pollution has recently been linked to diabetes and obesity. In a study conducted in 270 Boston residents by measuring 24 hour average ambient levels of air pollution (PM2.5, particle number, black carbon, and sulfates) approximately 500 m from the patient examination site, it was found that diabetes confers vulnerability to effects of particles associated with coal-burning power plants and traffic.112 Recently, in a high fat diet-induced obesity mouse model, PM2.5-exposed mice exhibited marked whole-body insulin resistance, systemic inflammation, and an increase in visceral adiposity, which was associated with abnormalities in vascular relaxation to insulin and acetylcholine, increased adipose tissue macrophages and inflammatory cell adhesion in the microcirculation, providing a new link between air pollution and type 2 diabetes mellitus.113

Conclusion

Cardiovascular diseases have caused significant human and public health burden, with sustained reductions in air pollution exposure associated with increased life expectancy.10 Although significant improvements have been achieved in terms of air quality in the past decades, “clear sky visibility” over land has decreased globally over the past 30 years (except in Europe),114 indicating that we still have a long way to go in reducing air pollution levels and associated diseases. Future investigations on air pollution-induced cardiovascular diseases must not only include more studies to determine the mechanisms of action, but also examine the role of each specific component of air pollution in order to determine what combination of particles is to blame for this sudden increase in environmental-induced health concerns. This information is paramount for policy makers to determine acceptable levels of air pollution and to design ways to minimize the harmful effects of particles on the body.

Acknowledgments

Sources of Funding This study was supported by grants from the National Institutes of Health (NIH) to Dr. Sun (ES016588 and ES017412) and from the American Heart Association to Dr. Wold (AHA0835298N).

Footnotes

Disclosures None.

This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Brook RD, Franklin B, Cascio W, Hong Y, Howard G, Lipsett M, Luepker R, Mittleman M, Samet J, Smith SC, Jr., Tager I. Air pollution and cardiovascular disease: a statement for healthcare professionals from the Expert Panel on Population and Prevention Science of the American Heart Association. Circulation. 2004;109:2655–2671. doi: 10.1161/01.CIR.0000128587.30041.C8. [DOI] [PubMed] [Google Scholar]
  • 2.Simkhovich BZ, Kleinman MT, Kloner RA. Air pollution and cardiovascular injury epidemiology, toxicology, and mechanisms. J Am Coll Cardiol. 2008;52:719–726. doi: 10.1016/j.jacc.2008.05.029. [DOI] [PubMed] [Google Scholar]
  • 3.Mills NL, Donaldson K, Hadoke PW, Boon NA, MacNee W, Cassee FR, Sandstrom T, Blomberg A, Newby DE. Adverse cardiovascular effects of air pollution. Nat Clin Pract Cardiovasc Med. 2009;6:36–44. doi: 10.1038/ncpcardio1399. [DOI] [PubMed] [Google Scholar]
  • 4.US Environmental Protection Agency [Accessibility verified November 4, 2009]; http://www.epa.gov/air/particlepollution/ [PubMed]
  • 5.Dockery DW, Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, Ferris BG, Speizer FE. An Association between Air Pollution and Mortality in Six U.S. Cities. N Engl J Med. 1993;329:1753–1759. doi: 10.1056/NEJM199312093292401. [DOI] [PubMed] [Google Scholar]
  • 6.Hoek G, Brunekreef B, Goldbohm S, Fischer P, van den Brandt PA. Association between mortality and indicators of traffic-related air pollution in the Netherlands: a cohort study. Lancet. 2002;360:1203–1209. doi: 10.1016/S0140-6736(02)11280-3. [DOI] [PubMed] [Google Scholar]
  • 7.Pope CA, 3rd, Burnett RT, Thurston GD, Thun MJ, Calle EE, Krewski D, Godleski JJ. Cardiovascular mortality and long-term exposure to particulate air pollution: epidemiological evidence of general pathophysiological pathways of disease. Circulation. 2004;109:71–77. doi: 10.1161/01.CIR.0000108927.80044.7F. [DOI] [PubMed] [Google Scholar]
  • 8.Pope CA, 3rd, Muhlestein JB, May HT, Renlund DG, Anderson JL, Horne BD. Ischemic heart disease events triggered by short-term exposure to fine particulate air pollution. Circulation. 2006;114:2443–2448. doi: 10.1161/CIRCULATIONAHA.106.636977. [DOI] [PubMed] [Google Scholar]
  • 9.Miller KA, Siscovick DS, Sheppard L, Shepherd K, Sullivan JH, Anderson GL, Kaufman JD. Long-term exposure to air pollution and incidence of cardiovascular events in women. N Engl J Med. 2007;356:447–458. doi: 10.1056/NEJMoa054409. [DOI] [PubMed] [Google Scholar]
  • 10.Pope CA, 3rd, Ezzati M, Dockery DW. Fine-particulate air pollution and life expectancy in the United States. N Engl J Med. 2009;360:376–386. doi: 10.1056/NEJMsa0805646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Brunekreef B. Air pollution and life expectancy: is there a relation? Occup Environ Med. 1997;54:781–784. doi: 10.1136/oem.54.11.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Nevalainen J, Pekkanen J. The effect of particulate air pollution on life expectancy. Sci Total Environ. 1998;217:137–141. doi: 10.1016/s0048-9697(98)00172-7. [DOI] [PubMed] [Google Scholar]
  • 13.Coyle D, Stieb D, Burnett RT, DeCivita P, Krewski D, Chen Y, Thun MJ. Impact of particulate air pollution on quality-adjusted life expectancy in Canada. J Toxicol Environ Health A. 2003;66:1847–1863. doi: 10.1080/15287390306447. [DOI] [PubMed] [Google Scholar]
  • 14.Schulz H, Harder V, Ibald-Mulli A, Khandoga A, Koenig W, Krombach F, Radykewicz R, Stampfl A, Thorand B, Peters A. Cardiovascular effects of fine and ultrafine particles. J Aerosol Med. 2005;18:1–22. doi: 10.1089/jam.2005.18.1. [DOI] [PubMed] [Google Scholar]
  • 15.Effect of Air Pollution on Health: Report of the Committee on Public Health Relations of The New York Academy of Medicine. Bull N Y Acad Med. 1931;7:751–775. [PMC free article] [PubMed] [Google Scholar]
  • 16.Haagen-Smit AJ. A lesson from the smog capital of the world. Proc Natl Acad Sci U S A. 1970;67:887–897. doi: 10.1073/pnas.67.2.887. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sultz HA, Feldman JG, Schlesinger ER, Mosher WE. An effect of continued exposure to air pollution on the incidence of chronic childhood allergic disease. Am J Public Health Nations Health. 1970;60:891–900. doi: 10.2105/ajph.60.5.891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Leeder SR, Pengelly LD. Epidemiological bases for ambient air quality criteria. Aust N Z J Med. 1977;7:78–87. doi: 10.1111/j.1445-5994.1977.tb03362.x. [DOI] [PubMed] [Google Scholar]
  • 19.Burnett RT, Dales RE, Brook JR, Raizenne ME, Krewski D. Association between ambient carbon monoxide levels and hospitalizations for congestive heart failure in the elderly in 10 Canadian cities. Epidemiology. 1997;8:162–167. doi: 10.1097/00001648-199703000-00007. [DOI] [PubMed] [Google Scholar]
  • 20.Burnett RT, Cakmak S, Brook JR, Krewski D. The role of particulate size and chemistry in the association between summertime ambient air pollution and hospitalization for cardiorespiratory diseases. Environ Health Perspect. 1997;105:614–620. doi: 10.1289/ehp.97105614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Schwartz J. Air pollution and daily mortality: a review and meta analysis. Environ Res. 1994;64:36–52. doi: 10.1006/enrs.1994.1005. [DOI] [PubMed] [Google Scholar]
  • 22.Schwartz J. What are people dying of on high air pollution days? Environ Res. 1994;64:26–35. doi: 10.1006/enrs.1994.1004. [DOI] [PubMed] [Google Scholar]
  • 23.Schwartz J. Air pollution and hospital admissions for cardiovascular disease in Tucson. Epidemiology. 1997;8:371–377. doi: 10.1097/00001648-199707000-00004. [DOI] [PubMed] [Google Scholar]
  • 24.Nel A. Atmosphere. Air pollution-related illness: effects of particles. Science. 2005;308:804–806. doi: 10.1126/science.1108752. [DOI] [PubMed] [Google Scholar]
  • 25.Peters A, Dockery DW, Muller JE, Mittleman MA. Increased particulate air pollution and the triggering of myocardial infarction. Circulation. 2001;103:2810–2815. doi: 10.1161/01.cir.103.23.2810. [DOI] [PubMed] [Google Scholar]
  • 26.Peters A, Frohlich M, Doring A, Immervoll T, Wichmann HE, Hutchinson WL, Pepys MB, Koenig W. Particulate air pollution is associated with an acute phase response in men; results from the MONICA-Augsburg Study. Eur Heart J. 2001;22:1198–1204. doi: 10.1053/euhj.2000.2483. [DOI] [PubMed] [Google Scholar]
  • 27.Dominici F, Peng RD, Bell ML, Pham L, McDermott A, Zeger SL, Samet JM. Fine particulate air pollution and hospital admission for cardiovascular and respiratory diseases. Jama. 2006;295:1127–1134. doi: 10.1001/jama.295.10.1127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zanobetti A, Schwartz J. The effect of particulate air pollution on emergency admissions for myocardial infarction: a multicity case-crossover analysis. Environ Health Perspect. 2005;113:978–982. doi: 10.1289/ehp.7550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Wellenius GA, Bateson TF, Mittleman MA, Schwartz J. Particulate air pollution and the rate of hospitalization for congestive heart failure among medicare beneficiaries in Pittsburgh, Pennsylvania. Am J Epidemiol. 2005;161:1030–1036. doi: 10.1093/aje/kwi135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wellenius GA, Schwartz J, Mittleman MA. Particulate air pollution and hospital admissions for congestive heart failure in seven United States cities. Am J Cardiol. 2006;97:404–408. doi: 10.1016/j.amjcard.2005.08.061. [DOI] [PubMed] [Google Scholar]
  • 31.Bell ML, Ebisu K, Peng RD, Walker J, Samet JM, Zeger SL, Dominici F. Seasonal and regional short-term effects of fine particles on hospital admissions in 202 US counties, 1999-2005. Am J Epidemiol. 2008;168:1301–1310. doi: 10.1093/aje/kwn252. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bell ML, Ebisu K, Peng RD, Samet JM, Dominici F. Hospital admissions and chemical composition of fine particle air pollution. Am J Respir Crit Care Med. 2009;179:1115–1120. doi: 10.1164/rccm.200808-1240OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Levy D, Gent M, Newhouse MT. Relationship between acute respiratory illness and air pollution levels in an industrial city. Am Rev Respir Dis. 1977;116:167–173. doi: 10.1164/arrd.1977.116.2.167. [DOI] [PubMed] [Google Scholar]
  • 34.Morgan G, Corbett S, Wlodarczyk J. Air pollution and hospital admissions in Sydney, Australia, 1990 to 1994. Am J Public Health. 1998;88:1761–1766. doi: 10.2105/ajph.88.12.1761. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Schwartz J. Air pollution and hospital admissions for heart disease in eight U.S. counties. Epidemiology. 1999;10:17–22. [PubMed] [Google Scholar]
  • 36.Prescott GJ, Cohen GR, Elton RA, Fowkes FG, Agius RM. Urban air pollution and cardiopulmonary ill health: a 14.5 year time series study. Occup Environ Med. 1998;55:697–704. doi: 10.1136/oem.55.10.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Linn WS, Szlachcic Y, Gong H, Jr., Kinney PL, Berhane KT. Air pollution and daily hospital admissions in metropolitan Los Angeles. Environ Health Perspect. 2000;108:427–434. doi: 10.1289/ehp.00108427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Janssen NA, Schwartz J, Zanobetti A, Suh HH. Air conditioning and source-specific particles as modifiers of the effect of PM(10) on hospital admissions for heart and lung disease. Environ Health Perspect. 2002;110:43–49. doi: 10.1289/ehp.0211043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Wong CM, Atkinson RW, Anderson HR, Hedley AJ, Ma S, Chau PY, Lam TH. A tale of two cities: effects of air pollution on hospital admissions in Hong Kong and London compared. Environ Health Perspect. 2002;110:67–77. doi: 10.1289/ehp.0211067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.McGowan JA, Hider RN, Chacko E, Town GI. Particulate air pollution and hospital admissions in Christchurch, New Zealand. Aust N Z J Public Health. 2002;26:23–29. doi: 10.1111/j.1467-842x.2002.tb00266.x. [DOI] [PubMed] [Google Scholar]
  • 41.Mann JK, Tager IB, Lurmann F, Segal M, Quesenberry CP, Jr., Lugg MM, Shan J, Van Den Eeden SK. Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia. Environ Health Perspect. 2002;110:1247–1252. doi: 10.1289/ehp.021101247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Koken PJ, Piver WT, Ye F, Elixhauser A, Olsen LM, Portier CJ. Temperature, air pollution, and hospitalization for cardiovascular diseases among elderly people in Denver. Environ Health Perspect. 2003;111:1312–1317. doi: 10.1289/ehp.5957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Fung KY, Luginaah I, Gorey KM, Webster G. Air pollution and daily hospital admissions for cardiovascular diseases in Windsor, Ontario. Can J Public Health. 2005;96:29–33. doi: 10.1007/BF03404010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Chang CC, Tsai SS, Ho SC, Yang CY. Air pollution and hospital admissions for cardiovascular disease in Taipei, Taiwan. Environ Res. 2005;98:114–119. doi: 10.1016/j.envres.2004.07.005. [DOI] [PubMed] [Google Scholar]
  • 45.Hosseinpoor AR, Forouzanfar MH, Yunesian M, Asghari F, Naieni KH, Farhood D. Air pollution and hospitalization due to angina pectoris in Tehran, Iran: a time-series study. Environ Res. 2005;99:126–131. doi: 10.1016/j.envres.2004.12.004. [DOI] [PubMed] [Google Scholar]
  • 46.Maheswaran R, Haining RP, Brindley P, Law J, Pearson T, Fryers PR, Wise S, Campbell MJ. Outdoor air pollution, mortality, and hospital admissions from coronary heart disease in Sheffield, UK: a small-area level ecological study. Eur Heart J. 2005;26:2543–2549. doi: 10.1093/eurheartj/ehi457. [DOI] [PubMed] [Google Scholar]
  • 47.Wellenius GA, Schwartz J, Mittleman MA. Air pollution and hospital admissions for ischemic and hemorrhagic stroke among medicare beneficiaries. Stroke. 2005;36:2549–2553. doi: 10.1161/01.STR.0000189687.78760.47. [DOI] [PubMed] [Google Scholar]
  • 48.Low RB, Bielory L, Qureshi AI, Dunn V, Stuhlmiller DF, Dickey DA. The relation of stroke admissions to recent weather, airborne allergens, air pollution, seasons, upper respiratory infections, and asthma incidence, September 11, 2001, and day of the week. Stroke. 2006;37:951–957. doi: 10.1161/01.STR.0000214681.94680.66. [DOI] [PubMed] [Google Scholar]
  • 49.Barnett AG, Williams GM, Schwartz J, Best TL, Neller AH, Petroeschevsky AL, Simpson RW. The effects of air pollution on hospitalizations for cardiovascular disease in elderly people in Australian and New Zealand cities. Environ Health Perspect. 2006;114:1018–1023. doi: 10.1289/ehp.8674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Johnston FH, Bailie RS, Pilotto LS, Hanigan IC. Ambient biomass smoke and cardio-respiratory hospital admissions in Darwin, Australia. BMC Public Health. 2007;7:240. doi: 10.1186/1471-2458-7-240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Migliaretti G, Dalmasso P, Gregori D. Air pollution effects on the respiratory health of the resident adult population in Turin, Italy. Int J Environ Health Res. 2007;17:369–379. doi: 10.1080/09603120701628768. [DOI] [PubMed] [Google Scholar]
  • 52.Peng RD, Chang HH, Bell ML, McDermott A, Zeger SL, Samet JM, Dominici F. Coarse particulate matter air pollution and hospital admissions for cardiovascular and respiratory diseases among Medicare patients. Jama. 2008;299:2172–2179. doi: 10.1001/jama.299.18.2172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Yang CY. Air pollution and hospital admissions for congestive heart failure in a subtropical city: Taipei, Taiwan. J Toxicol Environ Health A. 2008;71:1085–1090. doi: 10.1080/15287390802114428. [DOI] [PubMed] [Google Scholar]
  • 54.Middleton N, Yiallouros P, Kleanthous S, Kolokotroni O, Schwartz J, Dockery DW, Demokritou P, Koutrakis P. A 10-year time-series analysis of respiratory and cardiovascular morbidity in Nicosia, Cyprus: the effect of short-term changes in air pollution and dust storms. Environ Health. 2008;7:39. doi: 10.1186/1476-069X-7-39. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Lin S, Bell EM, Liu W, Walker RJ, Kim NK, Hwang SA. Ambient ozone concentration and hospital admissions due to childhood respiratory diseases in New York State, 1991-2001. Environ Res. 2008;108:42–47. doi: 10.1016/j.envres.2008.06.007. [DOI] [PubMed] [Google Scholar]
  • 56.Gold DR, Litonjua A, Schwartz J, Lovett E, Larson A, Nearing B, Allen G, Verrier M, Cherry R, Verrier R. Ambient pollution and heart rate variability. Circulation. 2000;101:1267–1273. doi: 10.1161/01.cir.101.11.1267. [DOI] [PubMed] [Google Scholar]
  • 57.Pope CA, 3rd, Verrier RL, Lovett EG, Larson AC, Raizenne ME, Kanner RE, Schwartz J, Villegas GM, Gold DR, Dockery DW. Heart rate variability associated with particulate air pollution. Am Heart J. 1999;138:890–899. doi: 10.1016/s0002-8703(99)70014-1. [DOI] [PubMed] [Google Scholar]
  • 58.Pekkanen J, Peters A, Hoek G, Tiittanen P, Brunekreef B, de Hartog J, Heinrich J, Ibald-Mulli A, Kreyling WG, Lanki T, Timonen KL, Vanninen E. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease: the Exposure and Risk Assessment for Fine and Ultrafine Particles in Ambient Air (ULTRA) study. Circulation. 2002;106:933–938. doi: 10.1161/01.cir.0000027561.41736.3c. [DOI] [PubMed] [Google Scholar]
  • 59.Van Hee VC, Adar SD, Szpiro AA, Barr RG, Bluemke DA, Roux AV Diez, Gill EA, Sheppard L, Kaufman JD. Exposure to traffic and left ventricular mass and function: the Multi-Ethnic Study of Atherosclerosis. Am J Respir Crit Care Med. 2009;179:827–834. doi: 10.1164/rccm.200808-1344OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Chen LC, Hwang JS. Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice. IV. Characterization of acute and chronic effects of ambient air fine particulate matter exposures on heart-rate variability. Inhal Toxicol. 2005;17:209–216. doi: 10.1080/08958370590912789. [DOI] [PubMed] [Google Scholar]
  • 61.Devlin RB, Ghio AJ, Kehrl H, Sanders G, Cascio W. Elderly humans exposed to concentrated air pollution particles have decreased heart rate variability. Eur Respir J Suppl. 2003;40:76s–80s. doi: 10.1183/09031936.03.00402403. [DOI] [PubMed] [Google Scholar]
  • 62.Schwartz J, Litonjua A, Suh H, Verrier M, Zanobetti A, Syring M, Nearing B, Verrier R, Stone P, MacCallum G, Speizer FE, Gold DR. Traffic related pollution and heart rate variability in a panel of elderly subjects. Thorax. 2005;60:455–461. doi: 10.1136/thx.2004.024836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Routledge HC, Manney S, Harrison RM, Ayres JG, Townend JN. Effect of inhaled sulphur dioxide and carbon particles on heart rate variability and markers of inflammation and coagulation in human subjects. Heart. 2006;92:220–227. doi: 10.1136/hrt.2004.051672. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Corey LM, Baker C, Luchtel DL. Heart-rate variability in the apolipoprotein E knockout transgenic mouse following exposure to Seattle particulate matter. J Toxicol Environ Health A. 2006;69:953–965. doi: 10.1080/15287390500362105. [DOI] [PubMed] [Google Scholar]
  • 65.Min KB, Min JY, Cho SI, Paek D. The relationship between air pollutants and heart-rate variability among community residents in Korea. Inhal Toxicol. 2008;20:435–444. doi: 10.1080/08958370801903834. [DOI] [PubMed] [Google Scholar]
  • 66.Nemmar A, Hoylaerts MF, Hoet PH, Dinsdale D, Smith T, Xu H, Vermylen J, Nemery B. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am J Respir Crit Care Med. 2002;166:998–1004. doi: 10.1164/rccm.200110-026OC. [DOI] [PubMed] [Google Scholar]
  • 67.Nemmar A, Hoylaerts MF, Hoet PH, Vermylen J, Nemery B. Size effect of intratracheally instilled particles on pulmonary inflammation and vascular thrombosis. Toxicol Appl Pharmacol. 2003;186:38–45. doi: 10.1016/s0041-008x(02)00024-8. [DOI] [PubMed] [Google Scholar]
  • 68.Nemmar A, Hoet PH, Dinsdale D, Vermylen J, Hoylaerts MF, Nemery B. Diesel exhaust particles in lung acutely enhance experimental peripheral thrombosis. Circulation. 2003;107:1202–1208. doi: 10.1161/01.cir.0000053568.13058.67. [DOI] [PubMed] [Google Scholar]
  • 69.Nemmar A, Nemery B, Hoet PH, Vermylen J, Hoylaerts MF. Pulmonary inflammation and thrombogenicity caused by diesel particles in hamsters: role of histamine. Am J Respir Crit Care Med. 2003;168:1366–1372. doi: 10.1164/rccm.200306-801OC. [DOI] [PubMed] [Google Scholar]
  • 70.Nemmar A, Hoylaerts MF, Hoet PH, Nemery B. Possible mechanisms of the cardiovascular effects of inhaled particles: systemic translocation and prothrombotic effects. Toxicol Lett. 2004;149:243–253. doi: 10.1016/j.toxlet.2003.12.061. [DOI] [PubMed] [Google Scholar]
  • 71.Nemmar A, Hoet PH, Vermylen J, Nemery B, Hoylaerts MF. Pharmacological stabilization of mast cells abrogates late thrombotic events induced by diesel exhaust particles in hamsters. Circulation. 2004;110:1670–1677. doi: 10.1161/01.CIR.0000142053.13921.21. [DOI] [PubMed] [Google Scholar]
  • 72.Peters A, Doring A, Wichmann HE, Koenig W. Increased plasma viscosity during an air pollution episode: a link to mortality? Lancet. 1997;349:1582–1587. doi: 10.1016/S0140-6736(97)01211-7. [DOI] [PubMed] [Google Scholar]
  • 73.Hoek G, Brunekreef B, Fischer P, van Wijnen J. The association between air pollution and heart failure, arrhythmia, embolism, thrombosis, and other cardiovascular causes of death in a time series study. Epidemiology. 2001;12:355–357. doi: 10.1097/00001648-200105000-00017. [DOI] [PubMed] [Google Scholar]
  • 74.Lucking AJ, Lundback M, Mills NL, Faratian D, Barath SL, Pourazar J, Cassee FR, Donaldson K, Boon NA, Badimon JJ, Sandstrom T, Blomberg A, Newby DE. Diesel exhaust inhalation increases thrombus formation in man. Eur Heart J. 2008;29:3043–3051. doi: 10.1093/eurheartj/ehn464. [DOI] [PubMed] [Google Scholar]
  • 75.Pekkanen J, Brunner EJ, Anderson HR, Tiittanen P, Atkinson RW. Daily concentrations of air pollution and plasma fibrinogen in London. Occup Environ Med. 2000;57:818–822. doi: 10.1136/oem.57.12.818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Schwartz J. Air pollution and blood markers of cardiovascular risk. Environ Health Perspect. 2001;109(Suppl 3):405–409. doi: 10.1289/ehp.01109s3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Davies MJ. The pathophysiology of acute coronary syndromes. Heart. 2000;83:361–366. doi: 10.1136/heart.83.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Rosenberg RD, Aird WC. Vascular-bed--specific hemostasis and hypercoagulable states. N Engl J Med. 1999;340:1555–1564. doi: 10.1056/NEJM199905203402007. [DOI] [PubMed] [Google Scholar]
  • 79.Mills NL, Tornqvist H, Robinson SD, Gonzalez M, Darnley K, MacNee W, Boon NA, Donaldson K, Blomberg A, Sandstrom T, Newby DE. Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis. Circulation. 2005;112:3930–3936. doi: 10.1161/CIRCULATIONAHA.105.588962. [DOI] [PubMed] [Google Scholar]
  • 80.Mills NL, Tornqvist H, Robinson SD, Gonzalez MC, Soderberg S, Sandstrom T, Blomberg A, Newby DE, Donaldson K. Air pollution and atherothrombosis. Inhal Toxicol. 2007;19(Suppl 1):81–89. doi: 10.1080/08958370701495170. [DOI] [PubMed] [Google Scholar]
  • 81.Mills NL, Tornqvist H, Gonzalez MC, Vink E, Robinson SD, Soderberg S, Boon NA, Donaldson K, Sandstrom T, Blomberg A, Newby DE. Ischemic and thrombotic effects of dilute diesel-exhaust inhalation in men with coronary heart disease. N Engl J Med. 2007;357:1075–1082. doi: 10.1056/NEJMoa066314. [DOI] [PubMed] [Google Scholar]
  • 82.Newby DE, Wright RA, Labinjoh C, Ludlam CA, Fox KA, Boon NA, Webb DJ. Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. Circulation. 1999;99:1411–1415. doi: 10.1161/01.cir.99.11.1411. [DOI] [PubMed] [Google Scholar]
  • 83.Baccarelli A, Zanobetti A, Martinelli I, Grillo P, Hou L, Giacomini S, Bonzini M, Lanzani G, Mannucci PM, Bertazzi PA, Schwartz J. Effects of exposure to air pollution on blood coagulation. J Thromb Haemost. 2007;5:252–260. doi: 10.1111/j.1538-7836.2007.02300.x. [DOI] [PubMed] [Google Scholar]
  • 84.Baccarelli A, Martinelli I, Zanobetti A, Grillo P, Hou LF, Bertazzi PA, Mannucci PM, Schwartz J. Exposure to particulate air pollution and risk of deep vein thrombosis. Arch Intern Med. 2008;168:920–927. doi: 10.1001/archinte.168.9.920. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Baccarelli A, Martinelli I, Pegoraro V, Melly S, Grillo P, Zanobetti A, Hou L, Bertazzi PA, Mannucci PM, Schwartz J. Living near major traffic roads and risk of deep vein thrombosis. Circulation. 2009;119:3118–3124. doi: 10.1161/CIRCULATIONAHA.108.836163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Ray MR, Mukherjee S, Roychoudhury S, Bhattacharya P, Banerjee M, Siddique S, Chakraborty S, Lahiri T. Platelet activation, upregulation of CD11b/CD18 expression on leukocytes and increase in circulating leukocyte-platelet aggregates in Indian women chronically exposed to biomass smoke. Hum Exp Toxicol. 2006;25:627–635. doi: 10.1177/0960327106074603. [DOI] [PubMed] [Google Scholar]
  • 87.Penn A, Snyder CA. 1,3 Butadiene, a vapor phase component of environmental tobacco smoke, accelerates arteriosclerotic plaque development. Circulation. 1996;93:552–557. doi: 10.1161/01.cir.93.3.552. [DOI] [PubMed] [Google Scholar]
  • 88.Penn A, Snyder CA. Butadiene inhalation accelerates arteriosclerotic plaque development in cockerels. Toxicology. 1996;113:351–354. doi: 10.1016/0300-483x(96)03472-5. [DOI] [PubMed] [Google Scholar]
  • 89.Suwa T, Hogg JC, Quinlan KB, Ohgami A, Vincent R, van Eeden SF. Particulate air pollution induces progression of atherosclerosis. J Am Coll Cardiol. 2002;39:935–942. doi: 10.1016/s0735-1097(02)01715-1. [DOI] [PubMed] [Google Scholar]
  • 90.Seaton A, MacNee W, Donaldson K, Godden D. Particulate air pollution and acute health effects. Lancet. 1995;345:176–178. doi: 10.1016/s0140-6736(95)90173-6. [DOI] [PubMed] [Google Scholar]
  • 91.Tan HH, Fiel MI, Sun Q, Guo J, Gordon RE, Chen LC, Friedman SL, Odin JA, Allina J. Kupffer cell activation by ambient air particulate matter exposure may exacerbate non-alcoholic fatty liver disease. J Immunotoxicol. 2009 doi: 10.3109/15476910903241704. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Sun Q, Wang A, Jin X, Natanzon A, Duquaine D, Brook RD, Aguinaldo JG, Fayad ZA, Fuster V, Lippmann M, Chen LC, Rajagopalan S. Long-term air pollution exposure and acceleration of atherosclerosis and vascular inflammation in an animal model. Jama. 2005;294:3003–3010. doi: 10.1001/jama.294.23.3003. [DOI] [PubMed] [Google Scholar]
  • 93.Sun Q, Yue P, Kirk RI, Wang A, Moatti D, Jin X, Lu B, Schecter AD, Lippmann M, Gordon T, Chen LC, Rajagopalan S. Ambient air particulate matter exposure and tissue factor expression in atherosclerosis. Inhal Toxicol. 2008;20:127–137. doi: 10.1080/08958370701821482. [DOI] [PubMed] [Google Scholar]
  • 94.Chen LC, Nadziejko C. Effects of subchronic exposures to concentrated ambient particles (CAPs) in mice. V. CAPs exacerbate aortic plaque development in hyperlipidemic mice. Inhal Toxicol. 2005;17:217–224. doi: 10.1080/08958370590912815. [DOI] [PubMed] [Google Scholar]
  • 95.Araujo JA, Barajas B, Kleinman M, Wang X, Bennett BJ, Gong KW, Navab M, Harkema J, Sioutas C, Lusis AJ, Nel AE. Ambient particulate pollutants in the ultrafine range promote early atherosclerosis and systemic oxidative stress. Circ Res. 2008;102:589–596. doi: 10.1161/CIRCRESAHA.107.164970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Kunzli N, Jerrett M, Mack WJ, Beckerman B, LaBree L, Gilliland F, Thomas D, Peters J, Hodis HN. Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect. 2005;113:201–206. doi: 10.1289/ehp.7523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Hoffmann B, Moebus S, Mohlenkamp S, Stang A, Lehmann N, Dragano N, Schmermund A, Memmesheimer M, Mann K, Erbel R, Jockel KH. Residential exposure to traffic is associated with coronary atherosclerosis. Circulation. 2007;116:489–496. doi: 10.1161/CIRCULATIONAHA.107.693622. [DOI] [PubMed] [Google Scholar]
  • 98.Allen RW, Criqui MH, Diez Roux AV, Allison M, Shea S, Detrano R, Sheppard L, Wong ND, Stukovsky KH, Kaufman JD. Fine particulate matter air pollution, proximity to traffic, and aortic atherosclerosis. Epidemiology. 2009;20:254–264. doi: 10.1097/EDE.0b013e31819644cc. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Ibald-Mulli A, Stieber J, Wichmann HE, Koenig W, Peters A. Effects of air pollution on blood pressure: a population-based approach. Am J Public Health. 2001;91:571–577. doi: 10.2105/ajph.91.4.571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Zanobetti A, Canner MJ, Stone PH, Schwartz J, Sher D, Eagan-Bengston E, Gates KA, Hartley LH, Suh H, Gold DR. Ambient pollution and blood pressure in cardiac rehabilitation patients. Circulation. 2004;110:2184–2189. doi: 10.1161/01.CIR.0000143831.33243.D8. [DOI] [PubMed] [Google Scholar]
  • 101.Volpino P, Tomei F, La Valle C, Tomao E, Rosati MV, Ciarrocca M, De Sio S, Cangemi B, Vigliarolo R, Fedele F. Respiratory and cardiovascular function at rest and during exercise testing in a healthy working population: effects of outdoor traffic air pollution. Occup Med (Lond) 2004;54:475–482. doi: 10.1093/occmed/kqh102. [DOI] [PubMed] [Google Scholar]
  • 102.Briet M, Collin C, Laurent S, Tan A, Azizi M, Agharazii M, Jeunemaitre X, Alhenc-Gelas F, Boutouyrie P. Endothelial function and chronic exposure to air pollution in normal male subjects. Hypertension. 2007;50:970–976. doi: 10.1161/HYPERTENSIONAHA.107.095844. [DOI] [PubMed] [Google Scholar]
  • 103.Delfino RJ, Sioutas C, Malik S. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect. 2005;113:934–946. doi: 10.1289/ehp.7938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Linn WS, Gong H, Jr., Clark KW, Anderson KR. Day-to-day particulate exposures and health changes in Los Angeles area residents with severe lung disease. J Air Waste Manag Assoc. 1999;49:108–115. doi: 10.1080/10473289.1999.10463890. [DOI] [PubMed] [Google Scholar]
  • 105.Brauer M, Ebelt ST, Fisher TV, Brumm J, Petkau AJ, Vedal S. Exposure of chronic obstructive pulmonary disease patients to particles: respiratory and cardiovascular health effects. J Expo Anal Environ Epidemiol. 2001;11:490–500. doi: 10.1038/sj.jea.7500195. [DOI] [PubMed] [Google Scholar]
  • 106.Gong H, Jr., Linn WS, Sioutas C, Terrell SL, Clark KW, Anderson KR, Terrell LL. Controlled exposures of healthy and asthmatic volunteers to concentrated ambient fine particles in Los Angeles. Inhal Toxicol. 2003;15:305–325. doi: 10.1080/08958370304455. [DOI] [PubMed] [Google Scholar]
  • 107.Brook RD, Brook JR, Urch B, Vincent R, Rajagopalan S, Silverman F. Inhalation of fine particulate air pollution and ozone causes acute arterial vasoconstriction in healthy adults. Circulation. 2002;105:1534–1536. doi: 10.1161/01.cir.0000013838.94747.64. [DOI] [PubMed] [Google Scholar]
  • 108.Sun Q, Yue P, Ying Z, Cardounel AJ, Brook RD, Devlin R, Hwang JS, Zweier JL, Chen LC, Rajagopalan S. Air Pollution Exposure Potentiates Hypertension Through Reactive Oxygen Species-Mediated Activation of Rho/ROCK. Arterioscler Thromb Vasc Biol. 2008;28:1760–1766. doi: 10.1161/ATVBAHA.108.166967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Ying Z, Yue P, Xu X, Zhong M, Sun Q, Mikolaj M, Wang A, Brook RD, Chen LC, Rajagopalan S. Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase. Am J Physiol Heart Circ Physiol. 2009;296:H1540–1550. doi: 10.1152/ajpheart.01270.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Knox EG. Meteorological associations of cerebrovascular disease mortality in England and Wales. J Epidemiol Community Health. 1981;35:220–223. doi: 10.1136/jech.35.3.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 111.Piver WT, Ando M, Ye F, Portier CJ. Temperature and air pollution as risk factors for heat stroke in Tokyo, July and August 1980-1995. Environ Health Perspect. 1999;107:911–916. doi: 10.1289/ehp.99107911. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.O’Neill MS, Veves A, Zanobetti A, Sarnat JA, Gold DR, Economides PA, Horton ES, Schwartz J. Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation. 2005;111:2913–2920. doi: 10.1161/CIRCULATIONAHA.104.517110. [DOI] [PubMed] [Google Scholar]
  • 113.Sun Q, Yue P, Deiuliis JA, Lumeng CN, Kampfrath T, Mikolaj MB, Cai Y, Ostrowski MC, Lu B, Parthasarathy S, Brook RD, Moffatt-Bruce SD, Chen LC, Rajagopalan S. Ambient Air Pollution Exaggerates Adipose Inflammation and Insulin Resistance in a Mouse Model of Diet-Induced Obesity. Circulation. 2009;119:538–546. doi: 10.1161/CIRCULATIONAHA.108.799015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Wang K, Dickinson RE, Liang S. Clear sky visibility has decreased over land globally from 1973 to 2007. Science. 2009;323:1468–1470. doi: 10.1126/science.1167549. [DOI] [PubMed] [Google Scholar]

RESOURCES